DRIVIN G ROWTH - Dr. Reddy's
DRIVIN G ROWTH - Dr. Reddy's
DRIVIN G ROWTH - Dr. Reddy's
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
REDDY PHARMACEUTICALS HONG<br />
KONG LTD.<br />
REDDY PHARMACEUTICALS Hong<br />
Kong Ltd. registered sales of US$ 4,733<br />
thousands for the year ended December 31,<br />
2001 as compared to US$ 2,017 thousands<br />
for the year ended December 31, 2000,<br />
which marks a growth of 134.6%. Net<br />
profit for the current year as well as the<br />
previous year was US$ 90 thousands. The<br />
Company declared a dividend of US$ 75<br />
thousands for the year ended December 31,<br />
2001.<br />
REDDY BIOMED LTD.<br />
REDDY BIOMED Ltd recorded a<br />
decrease in turnover of 57.5% to Rub<br />
226,110 thousands for the year ended<br />
December 31, 2001 as against Rub 531,814<br />
thousands for the year ended December 31,<br />
2000. Net loss for the year was Rub 45,645<br />
thousands as compared to a net profit of<br />
Rub 10,818 thousands for the previous<br />
year.<br />
DR.REDDY’S FARMACEUTICA DO<br />
BRASIL LTDA.<br />
DR.REDDY’S FARMACEUTICA Do<br />
Brasil Ltda., a wholly owned subsidiary of<br />
our Company has been incorporated to<br />
establish operations in critical care products<br />
in the Brazilian market. Commercial<br />
operations has not commenced and the<br />
Company incurred a loss of Real 218 during<br />
the year ended December 31, 2001.<br />
DR. REDDY’S LABORATORIES INC.<br />
DURING THE CURRENT YEAR, the<br />
name of Reddy Cheminor Inc. has been<br />
changed to <strong>Dr</strong>. Reddy’s Laboratories, Inc..<br />
The Company recorded a turnover of<br />
US$ 125,647 thousands for the year ended<br />
March 31, 2002, a jump of 240.7% as<br />
against US$ 36,875 thousands for the<br />
previous year ended March 31, 2001.<br />
Revenues for the current year includes<br />
revenues from Fluoxetine Capsules 40 mg<br />
for which the Company had been granted<br />
180 days marketing exclusivity by USFDA.<br />
Net income for the year ended March 31,<br />
2002 was US$ 845 thousands as compared<br />
to a net loss of US$ 427 thousands for the<br />
previous year ended March 31, 2001.<br />
REDDY CHEMINOR S.A.<br />
REDDY CHEMINOR S.A recorded a<br />
6.0% increase in turnover at Euro 7,925<br />
thousands for the year ended March 31,<br />
2002 as against Euro 7,476 thousands for<br />
the previous year ended March 31, 2001.<br />
Net profit for the year ended March 31,<br />
2001 was at Euro 124 thousands as against<br />
DR. REDDY’S LABORATORIES LTD. | DIRECTORS’ REPORT | ANNUAL REPORT 2001-2002<br />
37
Change language